RhumbLine Advisers’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9K | Sell |
10,700
-63,555
| -86% | -$82.6K | ﹤0.01% | 3834 |
|
|
2025
Q1 | $103K | Buy |
74,255
+42,204
| +132% | +$58.7K | ﹤0.01% | 3380 |
|
|
2024
Q4 | $73.4K | Buy |
32,051
+1,590
| +5% | +$3.64K | ﹤0.01% | 3559 |
|
|
2024
Q3 | $82.8K | Buy |
30,461
+1,729
| +6% | +$4.7K | ﹤0.01% | 3560 |
|
|
2024
Q2 | $67.2K | Sell |
28,732
-5,125
| -15% | -$12K | ﹤0.01% | 3617 |
|
|
2024
Q1 | $159K | Buy |
33,857
+798
| +2% | +$3.74K | ﹤0.01% | 3279 |
|
|
2023
Q4 | $161K | Buy |
33,059
+9,012
| +37% | +$44K | ﹤0.01% | 3283 |
|
|
2023
Q3 | $112K | Buy |
24,047
+545
| +2% | +$2.53K | ﹤0.01% | 3426 |
|
|
2023
Q2 | $174K | Buy |
23,502
+3,887
| +20% | +$28.7K | ﹤0.01% | 3309 |
|
|
2023
Q1 | $160K | Buy |
19,615
+342
| +2% | +$2.79K | ﹤0.01% | 2786 |
|
|
2022
Q4 | $184K | Buy |
19,273
+829
| +4% | +$7.91K | ﹤0.01% | 2810 |
|
|
2022
Q3 | $217K | Buy |
18,444
+1,531
| +9% | +$18K | ﹤0.01% | 2866 |
|
|
2022
Q2 | $217K | Buy |
+16,913
| New | +$217K | ﹤0.01% | 2903 |
|